Registrieren
Registierung erfolgt in Kürze...
Details werden geladen...
UCLA Health study documents successful one-year outcome following first-ever bladder transplant | UCLA
The findings highlight key insights from two subsequent bladder transplants performed at UCLA Health.
Ähnliche Seiten
The First Year of Gut Health: What New Parents Need to Know About Baby Probiotics
https://www.soup.io/the-first-year-of-gut-health-what-new-parents-need-to-know-about-baby-probiotics
World Sickle Cell Day 2026: Apollo Hospitals Navi Mumbai Successfully Performs Bone Marrow Transplant On 33-Year-Old Patient
https://www.freepressjournal.in/mumbai/world-sickle-cell-day-2026-apollo-hospitals-navi-mumbai-successfully-performs-bone-marrow-transplant-on-33-year-old-patient
Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patient...
https://www.manilatimes.net/2026/05/23/tmt-newswire/globenewswire/abivax-presents-first-quarter-2026-financial-results-and-reports-three-year-interim-data-from-study-108-a-phase-2a2b-open-label-extension-trial-of-obefazimod-following-dose-de-escalation-in-patients-with-ulcerative-colitis/2350350Nerul Auto Driver Gets New Lease On Life After Wife Donates 65% Of Her Liver In First-Ever Transplant At NewEra Hospital
https://www.freepressjournal.in/mumbai/nerul-auto-driver-gets-new-lease-on-life-after-wife-donates-65-of-her-liver-in-first-ever-transplant-at-newera-hospitalRemix Therapeutics Announces Positive Data from Phase 1/2 ARIA Study of First-in-Class MYB mRNA Degrader, REM-422, in Patients with Adenoid Cystic Carcinoma (ACC) at the American Society of Clinical ...
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/remix-therapeutics-announces-positive-data-from-phase-12-aria-study-of-first-in-class-myb-mrna-degrader-rem-422-in-patients-with-adenoid-cystic-carcinoma-acc-at-the-american-society-of-clinical-oncology-annual-meeting-2026/2349708